e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Helus Pharma Inc.
Helus Pharma Announces Positive Topline Results from Phase 3 APPROACH Study evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder
November 16, 2026
From
Helus Pharma Inc.
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Reports Second Quarter Fiscal 2027 Financial Results and Recent Business Highlights
November 16, 2026
From
Helus Pharma Inc.
Via
GlobeNewswire
Tickers
HELP
Helus Pharma to Present Topline Results from Phase 3 APPROACH Study Evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder on November 16, 2026
November 15, 2026
From
Helus Pharma Inc.
Via
GlobeNewswire
Tickers
HELP
Helus Pharma to Participate in the Guggenheim Healthcare Innovation Conference
November 03, 2026
From
Helus Pharma Inc.
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Announces Co-Founders’ Transition from Executive Leadership as Company Advances Toward Next Stage of Development
October 27, 2026
From
Helus Pharma Inc.
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026
October 21, 2026
From
Helus Pharma Inc.
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors
October 15, 2026
From
Helus Pharma Inc.
Via
GlobeNewswire
Tickers
HELP
Helus Pharma to Host Investor Presentation on October 21, 2026
October 08, 2026
From
Helus Pharma Inc.
Via
GlobeNewswire
Tickers
HELP
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.